Published

The therapeutic potential of psychedelics: the European regulatory perspective

No abstract availability was recorded for this entry.

Open source BibTeX RIS

Bibliographic context

Journal: The Lancet
Date: 2023-02-10
Source: OpenAlex
DOI: 10.1016/s0140-6736(23)00264-7
PubMed: 36780909

Authors

Florence Butlen-Ducuing Drummond E-Wen McCulloch Marion Haberkamp Taina Mattila Ewa Bałkowiec-Iskra Georgios Aislaitner П. В. Балабанов Johan Lundberg Dea Siggaard Stenbæk André Elferink Gitte M. Knudsen Steffen Thirstrup

Watch author

Derived topics and classifications

psilocybin Addiction Other

Citation graph

0 referenced DOIs found in stored source metadata. 2 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Short-Term and Late-Term Effects of Psilocybin on Symptoms in Major Depression2026-05-15 The therapeutic potential of psychedelics: the European regulatory perspective2023-02-10

Related papers

PSilocybin Microdose for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site Phase 3 Double-blind, Placebo-controlled, Parallel-arm Clinical TrialClinicalTrials.gov · 2026-07-10 PSilocybin for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site, Open-label, Single Arm Phase I/II Proof-of-concept, Dose-finding, and Feasibility Clinical TrialClinicalTrials.gov · 2026-07-10 Lysergic Acid Diethylamide (LSD) in Palliative Care: a Randomised, Double-blind, Active-placebo Controlled Phase II Study (LPC-Study)ClinicalTrials.gov · 2026-04-29 An Exploratory Pilot Study of Palliadelic Treatment to Reduce Psychological Distress in People With Pancreatobiliary and Other Advanced Gastrointestinal CancersClinicalTrials.gov · 2026-08-19 Psilocybin-assisted Existential, Attachment and Relational (PEARL) Therapy for Caregivers of Patients With Advanced Cancer: A Phase II Open-Label TrialClinicalTrials.gov · 2026-06-23 Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy VolunteersClinicalTrials.gov · 2026-02-05 Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS SurvivorsClinicalTrials.gov · 2021-01-07